| Serial Number | 79184643 |
| Word Mark | GEVIMIS |
| Filing Date | Friday, January 22, 2016 |
| Status | 401 - IR CANCELLED - NO TRANSFORMATION FILED |
| Status Date | Friday, January 15, 2021 |
| Registration Number | 5029385 |
| Registration Date | Tuesday, August 30, 2016 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 14, 2016 |
| Certificate of Correction for Registration | In the statement, lines 4 through 21, " Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; " should be deleted. In the statement, " lines 22 through 24, " ; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma " should be inserted. |
| Goods and Services | [ Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; ] pharmaceutical products for the prevention and treatment of cancer and tumors [ ; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma ] |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | H - NOT AVAILABLE |
| Class Status Date | Thursday, October 17, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | NOVARTIS AG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | CH |
| Party Name | NOVARTIS AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | CH |
| Party Name | NOVARTIS AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | CH |
| Event Date | Event Description |
| Sunday, May 23, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Sunday, October 25, 2020 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
| Saturday, October 24, 2020 | DEATH OF INTERNATIONAL REGISTRATION |
| Friday, November 1, 2019 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
| Friday, November 1, 2019 | DEATH OF INTERNATIONAL REGISTRATION |
| Thursday, January 11, 2018 | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE |
| Tuesday, December 26, 2017 | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED |
| Wednesday, April 26, 2017 | LIMITATION FROM THE IB EXAMINED AND ENTERED |
| Wednesday, April 26, 2017 | CORRECTION UNDER SECTION 7 ¿ PROCESSED |
| Wednesday, April 26, 2017 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Friday, April 7, 2017 | LIMITATION OF GOODS RECEIVED FROM IB |
| Friday, October 21, 2016 | NOTIFICATION PROCESSED BY IB |
| Monday, October 3, 2016 | FINAL DISPOSITION NOTICE SENT TO IB |
| Monday, October 3, 2016 | FINAL DISPOSITION PROCESSED |
| Thursday, September 29, 2016 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB |
| Tuesday, August 30, 2016 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, July 28, 2016 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Tuesday, June 14, 2016 | PUBLISHED FOR OPPOSITION |
| Wednesday, June 1, 2016 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, June 1, 2016 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, May 25, 2016 | NOTICE OF PUBLICATION |
| Wednesday, May 4, 2016 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, May 2, 2016 | ASSIGNED TO EXAMINER |
| Friday, March 25, 2016 | APPLICATION FILING RECEIPT MAILED |
| Monday, March 21, 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Saturday, March 19, 2016 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Thursday, March 17, 2016 | SN ASSIGNED FOR SECT 66A APPL FROM IB |